Back to search
FDAFDA · Food and drugs·Recall number D-744-2014

Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 caplets. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02.

Published January 22, 2014 · Recall initiated: May 15, 2013

Summary

FDA records drug Class III recall D-744-2014, published January 22, 2014 and initiated May 15, 2013. Recalling firm: Novartis Consumer Health; Status: Terminated; Reported quantity: 2,978,000/2-caplet packages; Lot: Lot# 10118234 Exp 05/13 Lot# 10120254 Exp 05/13 Lot# 10123513 Exp 08/13 Lot#10125262 Exp 09/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Novartis Consumer Health
Distributor
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Lot
Lot# 10118234 Exp 05/13 Lot# 10120254 Exp 05/13 Lot# 10123513 Exp 08/13 Lot#10125262 Exp 09/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 caplets. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02. recalled?

Yes. FDA published recall D-744-2014 on January 22, 2014. Reported hazard: Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter